Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...

The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a large DNA payload into T cells in vivo.

New research shows epigenetic silencing may limit durability of AAV gene therapy in haemophilia by reducing long term transgene expression in liver cells.

Belief BioMed ("BBM") today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the Pharmaceutical Administration Bureau of Macao Special ...

Discussions of cognitive offloading often miss a critical distinction: What AI does to a 45-year-old's brain is categorically ...

Foundational research led by co-founder Justin Eyquem, Ph.D., underpins Azalea's proprietary in vivo CAR T platform -- Peer-reviewed publication demonstrates stable, cell-specific transgene expression ...

Tired of DLSS 4.5? Nvidia said DLSS 5 is on the way, and it’s bringing real-time slop-ification to PC gaming. The best I can ...

SHANGHAI, March 19, 2026 /PRNewswire/ -- Belief BioMed ("BBM") today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the Pharmaceutical ...

Researchers have engineered Arabidopsis plants that emit visible light when their immune defenses switch on, creating a living sensor that tracks how plants fight pathogens in real time. The work, ...

Macau Drug Administration approves Belief Pharmaceuticals’ haemophilia B gene therapy drug, Popidacoji injection: Shanghai, China Saturday, March 21, 2026, 17:00 Hrs [IST] Belie ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...